These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10632118)

  • 1. Gene-gene interaction between interleukin-6 and alpha2-macroglobulin influences the risk for Alzheimer's disease.
    Bagli M; Papassotiropoulos A; Jessen F; Rao ML; Maier W; Heun R
    Ann Neurol; 2000 Jan; 47(1):138-9. PubMed ID: 10632118
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK.
    Dow DJ; Lindsey N; Cairns NJ; Brayne C; Robinson D; Huppert FA; Paykel ES; Xuereb J; Wilcock G; Whittaker JL; Rubinsztein DC
    Nat Genet; 1999 May; 22(1):16-7; author reply 21-2. PubMed ID: 10319853
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses.
    Verpillat P; Bouley S; Hannequin D; Belliard S; Puel M; Thomas-Anterion C; Dubois B; Agid Y; Campion D; Clerget-Darpoux F; Brice A
    Ann Neurol; 2000 Sep; 48(3):400-2. PubMed ID: 10976654
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients.
    Camelo D; Arboleda G; Yunis JJ; Pardo R; Arango G; Solano E; López L; Hedmont D; Arboleda H
    J Neurol Sci; 2004 Mar; 218(1-2):47-51. PubMed ID: 14759632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
    Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
    J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
    Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
    Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
    Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
    Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
    Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
    Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
    Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
    Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease.
    Rogaeva EA; Premkumar S; Grubber J; Serneels L; Scott WK; Kawarai T; Song Y; Hill DL; Abou-Donia SM; Martin ER; Vance JJ; Yu G; Orlacchio A; Pei Y; Nishimura M; Supala A; Roberge B; Saunders AM; Roses AD; Schmechel D; Crane-Gatherum A; Sorbi S; Bruni A; Small GW; Conneally PM; Haines JL; Van Leuven F; St George-Hyslop PH; Farrer LA; Pericak-Vance MA
    Nat Genet; 1999 May; 22(1):19-22. PubMed ID: 10319855
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease.
    Poduslo SE; Shook B; Drigalenko E; Yin X
    Am J Med Genet; 2002 Jun; 110(1):30-5. PubMed ID: 12116268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha2-macroglobulin gene polymorphism in patients with Alzheimer's disease].
    Styczyńska M; Wasiak B; Łuczywek E; Pfeffer A; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1013-20. PubMed ID: 11987698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12.
    Panza F; Colacicco AM; D'Introno A; Capurso C; Liaci M; Capurso SA; Capurso A; Solfrizzi V
    Mech Ageing Dev; 2006 Jan; 127(1):36-47. PubMed ID: 16183100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese.
    Hu CJ; Sung SM; Liu HC; Lee KY; Hsu WC; Wong WK; Lee CC; Tsai CH; Chang JG
    Neurology; 1999 Aug; 53(3):642-3. PubMed ID: 10449138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin.
    Saunders AJ; Bertram L; Mullin K; Sampson AJ; Latifzai K; Basu S; Jones J; Kinney D; MacKenzie-Ingano L; Yu S; Albert MS; Moscarillo TJ; Go RC; Bassett SS; Daly MJ; Laird NM; Wang X; Velicelebi G; Wagner SL; Becker DK; Tanzi RE; Blacker D
    Hum Mol Genet; 2003 Nov; 12(21):2765-76. PubMed ID: 12966032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics.
    Romas SN; Mayeux R; Rabinowitz D; Tang MX; Zadroga HR; Lantigua R; Medrano M; Tycko B; Knowles JA
    Neurosci Lett; 2000 Feb; 279(3):133-6. PubMed ID: 10688047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Welcome to the complex disease world. Alpha2-macroglobulin and Alzheimer's disease.
    Saunders AJ; Tanzi RE
    Exp Neurol; 2003 Nov; 184(1):50-3. PubMed ID: 14637079
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample.
    Crawford F; Town T; Freeman M; Schinka J; Gold M; Duara R; Mullan M
    Neurosci Lett; 1999 Aug; 270(3):133-6. PubMed ID: 10462112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.
    Prince JA; Feuk L; Sawyer SL; Gottfries J; Ricksten A; Nägga K; Bogdanovic N; Blennow K; Brookes AJ
    Eur J Hum Genet; 2001 Jun; 9(6):437-44. PubMed ID: 11436125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.